Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $77

Benzinga · 1d ago
Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $73 to $77.